2.
    发明专利
    未知

    公开(公告)号:AT112967T

    公开(公告)日:1994-11-15

    申请号:AT90906364

    申请日:1990-04-25

    Abstract: An antithrombotic blood treating system comprising a combination of a permselective hollow fiber membrane containing a copolymer having a polyethylene oxide unit; a header having a blood-contacting surface coated with either a heparinized hydrophilic copolymer containing vinyl chloride as the constituent or a hydrophilic copolymer having a polyethylene oxide unit; a catheter; and a circuit. It becomes possible for the first time to conduct extracorporeal circulation for a long period of time without the necessity for internally administering heparin by imparting an antithrombotic property to the entire blood-contacting surface.

    3.
    发明专利
    未知

    公开(公告)号:FI94096B

    公开(公告)日:1995-04-13

    申请号:FI872625

    申请日:1987-06-12

    Abstract: This invention provides method and membrane for hemodialysis which has a total protein permeability of not more than 0.2%, and has a reduction rate of beta 2-microglobulin of not less than 5%. The hemodialysis membrane of the present invention selectively removes beta 2-microglobulin which was shown to cause some long-term complications such as carpel tunnel syndrome in the patients undergoing hemodialysis, while preventing the leakage of useful proteins.

    6.
    发明专利
    未知

    公开(公告)号:DE3777453D1

    公开(公告)日:1992-04-23

    申请号:DE3777453

    申请日:1987-06-09

    Abstract: This invention provides method and membrane for hemodialysis which has a total protein permeability of not more than 0.2%, and has a reduction rate of beta 2-microglobulin of not less than 5%. The hemodialysis membrane of the present invention selectively removes beta 2-microglobulin which was shown to cause some long-term complications such as carpel tunnel syndrome in the patients undergoing hemodialysis, while preventing the leakage of useful proteins.

    7.
    发明专利
    未知

    公开(公告)号:FI872625A0

    公开(公告)日:1987-06-12

    申请号:FI872625

    申请日:1987-06-12

    Abstract: This invention provides method and membrane for hemodialysis which has a total protein permeability of not more than 0.2%, and has a reduction rate of beta 2-microglobulin of not less than 5%. The hemodialysis membrane of the present invention selectively removes beta 2-microglobulin which was shown to cause some long-term complications such as carpel tunnel syndrome in the patients undergoing hemodialysis, while preventing the leakage of useful proteins.

    9.
    发明专利
    未知

    公开(公告)号:DE69013457T2

    公开(公告)日:1995-02-23

    申请号:DE69013457

    申请日:1990-04-25

    Abstract: An antithrombotic blood treating system comprising a combination of a permselective hollow fiber membrane containing a copolymer having a polyethylene oxide unit; a header having a blood-contacting surface coated with either a heparinized hydrophilic copolymer containing vinyl chloride as the constituent or a hydrophilic copolymer having a polyethylene oxide unit; a catheter; and a circuit. It becomes possible for the first time to conduct extracorporeal circulation for a long period of time without the necessity for internally administering heparin by imparting an antithrombotic property to the entire blood-contacting surface.

    10.
    发明专利
    未知

    公开(公告)号:ES2061030T3

    公开(公告)日:1994-12-01

    申请号:ES90906364

    申请日:1990-04-25

    Abstract: An antithrombotic blood treating system comprising a combination of a permselective hollow fiber membrane containing a copolymer having a polyethylene oxide unit; a header having a blood-contacting surface coated with either a heparinized hydrophilic copolymer containing vinyl chloride as the constituent or a hydrophilic copolymer having a polyethylene oxide unit; a catheter; and a circuit. It becomes possible for the first time to conduct extracorporeal circulation for a long period of time without the necessity for internally administering heparin by imparting an antithrombotic property to the entire blood-contacting surface.

Patent Agency Ranking